Professor Lutz Heinemann
Afon Technology is delighted to announce the appointment of Professor Lutz Heinemann as the newest member of its Clinical Advisory Board.
The “international diabetes expert” will bring his wealth of scientific knowledge to the Welsh tech company, which is developing the world’s first non-invasive wearable blood glucose sensor.
Professor Heinemann is the Managing Editor of the Journal of Diabetes Science and Technology, as well as a member of national and international diabetes associations.
In 1999, Professor Heinemann founded the clinical research organisation, Profil Institut für Stoffwechselforschung in Neuss, Germany, and remained CEO there until 2009.
Afon Technology’s CEO Sabih Chaudhry said: “We are thrilled to welcome Professor Heinemann to Afon Technology’s Clinical Advisory Board.
“His appointment marks a significant milestone in our journey towards revolutionising diabetes care.”
He added: “With his exceptional expertise and vast experience, we are confident that his contributions will be invaluable at this crucial stage of our development.
“As a renowned international diabetes expert, he brings a wealth of scientific knowledge that perfectly aligns with our vision of creating the world’s first non-invasive wearable blood glucose sensor.”
Afon Technology focuses on working towards the future of blood glucose monitoring which will benefit people around the world with diabetes.
The pioneering company is best known for developing the world’s first non-invasive, real-time and continuous blood glucose sensor. The device is worn on the inside of the wrist with or without a watch, and it feeds back to the user’s chosen smart device to display blood glucose data.
Unlike the current devices, it will measure blood glucose levels in real-time without the need to penetrate the skin at all, making it easier to manage the condition, reducing the risk of diabetes-related complications such as heart attack, stroke, blindness, kidney failure and limb amputations.
Companies such as Apple, Samsung and Google are rumoured to have been trying to develop non-invasive blood glucose monitoring, but so far none have been successful. Afon Technology hopes to win the race to this important milestone.
Preliminary clinical research gives people with diabetes hope that such a device could become a reality in the near future.
